Many women experience some form of emotional or physical discomfort a few days before their monthly menstrual cycle. This is known as Premenstrual syndrome (PMS) and tends to affect women mainly of childbearing age. Common complaints include bloating, breast tenderness, headaches and mood changes and can affect up to 75 per cent of women.
However, about 5 per cent of women experience premenstrual symptoms that are so severe they cause significant mental distress and interfere with work, school or relationships, thereby meeting the criteria for Premenstrual Dysphoric Disorder or PMDD.
Although commonly dismissed as trivial, PMDD can disrupt a woman’s life, her daily activities and relationships so completely, she may despair that life itself is not worth living, with almost 15 per cent of women with PMDD contemplating suicide.
PMDD is diagnosed when five or more of the following symptoms occur 7 to 10 days before the onset of menstruation and then resolve within a few days of the start of the menstrual period:
&empmargin;—anxiety, tension, irritability or “edginess”
&empmargin;—sadness, hopelessness, feeling of worthlessness
—sudden mood changes
—&empmargin;loss of interest in usual activities
—difficulty concentrating
—marked anger
—fatigue, lack of energy
—&empmargin;change in appetite, food cravings,
—&empmargin;insomnia (difficulty sleeping) or excessive sleeping
—&empmargin;physical symptoms such as bloating, breast tenderness, weight gain, joint or muscle pain, swelling of the extremities
Before a doctor is able to make a diagnosis of PMDD, it is important to rule out other disorders that can mimic PMS and PMDD such as depression, anxiety disorders, bipolar disorder, and conditions such as thyroid disease, endometriosis, fibroids, peri-menopause and other hormonal disorders.
Women who have a personal or family history of mood disorders, including major depression or postpartum depression are at a greater risk of developing PMDD.
In addition, obesity, stress and a history of trauma or sexual abuse can increase the likelihood of PMDD.
There is no single test that can diagnose PMS or PMDD. The main challenge in detecting PMDD is the ability to differentiate between PMS symptoms which may be distressing and annoying but not disabling and those complaints that are severe enough to interfere with activities, work, school or relationships.
A doctor may also request that a woman carefully record her symptoms on a daily basis for two to three full menstrual cycles.
There is currently a poor understanding of the exact cause of these premenstrual disorders. Many researchers believe that they are brought about by the rising and falling hormone levels that occur during a menstrual cycle.
Women with PMDD are thought to be very sensitive to these fluctuating levels that occur just before and during the menstrual period.
Recent studies have also shown a connection between PMDD and altered levels of serotonin, which is a chemical in the brain that helps with transmission of nerve signals.
This can therefore explain why a type of antidepressant medication that can slow the reuptake of this chemical serotonin has been shown to be effective for many women with PMDD.
These are called selective serotonin reuptake inhibitors (SSRIs) and are considered to be first-line treatment for PMDD as well as severe symptoms of PMS.
Studies have confirmed that these SSRIs antidepressant meds significantly reduce the symptoms of PMDD when compared with a placebo, with 60 to 90% responding to this treatment.
In addition, these drugs were found to help even quicker than when used for depression which means that women may not necessarily need to take them every day but can be used on an intermittent basis. Other types of antidepressants have not been shown to be effective.
Hormonal treatment such as use of the birth control pill may help with PMS but has not been shown to be of major benefit in PMDD.
Lifestyle changes such as dietary changes (avoiding caffeine, alcohol, sugar and eating smaller and less frequent meals), exercise and vitamin supplements have had conflicting results and their benefit is not confirmed.
The use of cognitive behaviour therapy has shown some modest improvement in PMDD but does need further research.
This involves the use of a form of psychotherapy in which negative thoughts about yourself and the world are challenged in order to alter unwanted behaviour patterns or treat mood disorders.
Ultimately, PMDD is a chronic condition that can have a serious impact on a women’s quality of life. It can occur irrespective of any socioeconomic, cultural or ethnic background. Fortunately, once diagnosed, a variety of treatment and self-care measures can effectively control the symptoms in most women.
If you are affected by any of these symptoms mentioned here, please contact your doctor.